Form 4: Geron Corp: Director O'Farrell Granted Stock Options
Statement of Changes in Beneficial Ownership
Geron Corporation reports that Director Elizabeth G. O'Farrell was granted a stock option for 220,000 shares.
Summary
- Director Elizabeth G. O'Farrell was granted a stock option for 220,000 shares of common stock.
- The stock option has an exercise price of $1.26 per share.
- The option is exercisable on May 20, 2026, and expires on May 19, 2036.
- The option vests 100% on the earlier of the next annual meeting or the first anniversary of the grant date, provided the reporting person remains in continuous service.
- This filing is a Form 4, indicating a change in beneficial ownership.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director, which is a common compensation practice and does not inherently signal positive or negative performance.
Positives
- Grant of stock options to a director can align management's interests with shareholders.
- The exercise price of $1.26 suggests a potential for upside if the stock price increases significantly.
Negatives
- The filing only details a grant of options, not the exercise or sale of shares, so immediate financial impact is not evident.
Risks
- The vesting of the option is contingent on the reporting person's continuous service, implying a risk of forfeiture if service is terminated.
- The value of the option is subject to market fluctuations of Geron Corporation's stock price.
Future Outlook
The future outlook for the stock option is dependent on the company's performance and stock price appreciation, as the option is exercisable and vests over time.
Industry Context
StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors to incentivize long-term performance and retention, especially for companies focused on drug development where significant time horizons are involved.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Elizabeth G. O'Farrell has granted power of attorney to Michelle Robertson, Ankita Patel, Agnieszka Cieplinska, and Katie Harmon of Geron Corporation to execute Forms 3, 4, and 5 on her behalf. | 2026-01-29 | Facilitates timely and accurate filing of ownership changes by designated company personnel. |
Stakeholder Impact
- Shareholders: The grant of options aligns director incentives with stock performance, potentially benefiting shareholders if the stock price rises.
- Employees: Indirectly, the company's ability to attract and retain directors through compensation packages can impact overall company stability and performance.
Next Steps
- The stock option will vest and become exercisable according to the terms outlined.
- The reporting person may choose to exercise the option at a future date, subject to vesting conditions and market conditions.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Earliest transaction date and option grant date. |
| 05/19/2036 | Expiration date of the stock option. |
| 05/26/2026 | Date of signature on the filing. |
| 01/29/2026 | Date of execution of the Power of Attorney. |
Keywords
Form 4, Stock Option, Beneficial Ownership, Director, Geron Corporation, GERN, SEC Filing, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.